Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

Correll Christoph U.; Cucchiaro Josephine; Silva Robert; Hsu Jay; Pikalov Andrei; Loebel Antony

首页> 外文期刊>CNS spectrums >Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

【24h】

Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

机译：精神分裂症中LuRasidone的长期安全性和有效性：一个22个月，开放式标签扩展研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective To evaluate the safety and effectiveness of lurasidone in the long-term treatment of patients with schizophrenia.

机译：目的探讨LuraAnidone在精神分裂症患者长期治疗中的安全性和有效性。

著录项

来源
《CNS spectrums》 |2016年第5期|共10页
作者
Correll Christoph U.; Cucchiaro Josephine; Silva Robert; Hsu Jay; Pikalov Andrei; Loebel Antony;
展开▼
作者单位

North Shore Long Isl Jewish Hlth Syst Glen Oaks Albert Einstein Coll Med Zucker Hillside Hosp;

Sunov Pharmaceut Inc Ft Lee NJ USA;

Sunov Pharmaceut Inc Ft Lee NJ USA;

Sunov Pharmaceut Inc Ft Lee NJ USA;

Sunov Pharmaceut Inc Ft Lee NJ USA;

Sunov Pharmaceut Inc Ft Lee NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Atypical antipsychotic; lurasidone; maintenance treatment; safety; schizophrenia;

机译：非典型抗精神病药;LURASIDONE;维护治疗;安全;精神分裂症;

相似文献

外文文献
中文文献
专利

1. Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study [J] . Correll Christoph U., Cucchiaro Josephine, Silva Robert, CNS spectrums . 2016,第5期

机译：精神分裂症中LuRasidone的长期安全性和有效性：一个22个月，开放式标签扩展研究
2. Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: Interim analysis of a 2-year open-label extension study [J] . DelBello M. P., Goldman R., Tocco M., Bipolar disorders. . 2019,第Suppla1期

机译：具有双极抑郁症儿童和青少年的长期治疗的安全性和有效性：2年开放标签扩展研究中的临时分析
3. Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: A 6-month, open-label, extension study [J] . CitromeL., WeidenP.J., McEvoyJ.P., CNS spectrums . 2014,第4期

机译：卢拉西酮在精神分裂症或精神分裂症患者转用其他抗精神病药的有效性：一项为期6个月的开放标签扩展研究
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week Open-Label Extension Study [O] . Masaomi Iyo, Jun Ishigooka, Masatoshi Nakamura, 2021

机译：精神分裂症患者Lura的安全性和有效性：12周开放标签扩展研究
7. F52. EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY [O] . Robert Goldman, Michael Tocco, Andrei Pikalov, 2018

机译：F52。 LURASIDONE在青少年与精神分裂症的疗效和安全性：24个月的临时分析，开放标签扩展研究

Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

摘要

著录项

相似文献

相关主题

期刊订阅